Trials / Not Yet Recruiting
Not Yet RecruitingNCT06373094
A Single Dose Escalation Study of HHT201 in Healthy Subjects
A Single-center, Open-label, Single-dose Ascending Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetic Profile of HHT201 (Donepezil Dihydroxynaphthalate for Injection) in Healthy Subjects
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- Shanghai Synergy Pharmaceutical Sciences Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 59 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the safety and pharmacokinetic profiles of HHT201 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Donepezil Dihydroxynaphthalate for Injection | HHT201 will be injected into the muscle of gluteus. |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
- First posted
- 2024-04-18
- Last updated
- 2024-04-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06373094. Inclusion in this directory is not an endorsement.